Catherine Seyler

Summary

Country: France

Publications

  1. ncbi Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa
    Catherine Seyler
    INSERM U593, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat, 33076 Bordeaux, France
    AIDS 21:1157-64. 2007
  2. ncbi Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis
    Catherine Seyler
    Programme PAC CI, Abidjan, Cote d Ivoire
    AIDS Res Hum Retroviruses 23:1338-47. 2007
  3. ncbi Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults
    Eugene Messou
    Programme PAC, CI, Abidjan, Cote d Ivoire
    Bull World Health Organ 86:435-42. 2008
  4. ncbi Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan
    Catherine Seyler
    INSERM U593, , , 33076 Bordeaux, France
    Am J Respir Crit Care Med 172:123-7. 2005
  5. ncbi Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants
    Siaka Toure
    Aconda Association, Abidjan, Cote d Ivoire
    AIDS 22:873-82. 2008
  6. ncbi Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa
    Raoul Moh
    Trivacan ANRS 1269 study group, Abidjan, France
    AIDS 21:2483-91. 2007
  7. ncbi Occult HBV infection in untreated HIV-infected adults in Côte d'Ivoire
    Thérèse N'Dri-Yoman
    Programme PAC CI, Abidjan, Cote d Ivoire
    Antivir Ther 15:1029-34. 2010
  8. ncbi Antiretroviral treatment changes in adults from Côte d'Ivoire: the roles of tuberculosis and pregnancy
    Eugene Messou
    INSERM U897, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    AIDS 24:93-9. 2010
  9. ncbi High incidence of atypical mycobacteriosis in African HIV-infected adults with low CD4 cell counts: a 6-year cohort study in Côte d'Ivoire
    Dominique Bonard
    Programme PAC-CI, Abidjan, , France
    AIDS 18:1961-4. 2004
  10. ncbi Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration
    Paula Braitstein
    Department of Medicine, Indiana University, Indianapolis, Indiana, USA
    J Womens Health (Larchmt) 17:47-55. 2008

Collaborators

Detail Information

Publications23

  1. ncbi Impact of genotypic drug resistance mutations on clinical and immunological outcomes in HIV-infected adults on HAART in West Africa
    Catherine Seyler
    INSERM U593, Universite Victor Segalen Bordeaux 2, 146 rue Leo Saignat, 33076 Bordeaux, France
    AIDS 21:1157-64. 2007
    ..To analyse the association between the presence of resistance mutations and treatment outcomes. The impact of HIV-1 drug resistance mutations in African adults on HAART has so far never been reported...
  2. ncbi Morbidity before and after HAART initiation in Sub-Saharan African HIV-infected adults: a recurrent event analysis
    Catherine Seyler
    Programme PAC CI, Abidjan, Cote d Ivoire
    AIDS Res Hum Retroviruses 23:1338-47. 2007
    ..In HIV-infected patients on ART, the incidence of severe morbidity varied with the past history of morbidity. The past history of morbidity should be taken into account when comparing HIV morbidity rates before and after ART initiation...
  3. ncbi Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults
    Eugene Messou
    Programme PAC, CI, Abidjan, Cote d Ivoire
    Bull World Health Organ 86:435-42. 2008
    ..We assessed the gain or loss in body mass index (BMI), alone or in combination with the gain or loss in CD4+ T-cell count (CD4), as a tool for predicting the response to ART...
  4. ncbi Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan
    Catherine Seyler
    INSERM U593, , , 33076 Bordeaux, France
    Am J Respir Crit Care Med 172:123-7. 2005
    ..If confirmed by others, this finding could lead to assessment of new patterns of time-limited tuberculosis secondary chemoprophylaxis during the period of initiation of HAART in sub-Saharan African adults...
  5. ncbi Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants
    Siaka Toure
    Aconda Association, Abidjan, Cote d Ivoire
    AIDS 22:873-82. 2008
    ..To assess the rates and determinants of mortality, loss to follow-up and immunological failure in a nongovernmental organization-implemented program of access to antiretroviral treatment in Côte d'Ivoire...
  6. ncbi Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa
    Raoul Moh
    Trivacan ANRS 1269 study group, Abidjan, France
    AIDS 21:2483-91. 2007
    ..To estimate the incidence and risk factors of mortality and severe morbidity during the first months following antiretroviral therapy (ART) initiation in West African adults...
  7. ncbi Occult HBV infection in untreated HIV-infected adults in Côte d'Ivoire
    Thérèse N'Dri-Yoman
    Programme PAC CI, Abidjan, Cote d Ivoire
    Antivir Ther 15:1029-34. 2010
    ..Here, we estimated the prevalence of untreated HIV-infected adults with negative serum HBsAg and detectable plasma HBV DNA in Côte d'Ivoire...
  8. ncbi Antiretroviral treatment changes in adults from Côte d'Ivoire: the roles of tuberculosis and pregnancy
    Eugene Messou
    INSERM U897, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    AIDS 24:93-9. 2010
    ..To determine the rates and causes of first antiretroviral treatment changes in HIV-infected adults in Côte d'Ivoire...
  9. ncbi High incidence of atypical mycobacteriosis in African HIV-infected adults with low CD4 cell counts: a 6-year cohort study in Côte d'Ivoire
    Dominique Bonard
    Programme PAC-CI, Abidjan, , France
    AIDS 18:1961-4. 2004
    ..In sub-Saharan Africa, where most patients start highly active antiretroviral therapy with low CD4 cell counts, improving the diagnosis of NTM may be relevant...
  10. ncbi Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration
    Paula Braitstein
    Department of Medicine, Indiana University, Indianapolis, Indiana, USA
    J Womens Health (Larchmt) 17:47-55. 2008
    ....
  11. ncbi The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire
    Elena Losina
    Department of Biostatistics and Epidemiology, Boston University School of Public Health, Boston, MA, USA
    Antivir Ther 12:543-51. 2007
    ..Studies in developed countries have shown highly active antiretroviral therapy (HAART) decreases incidence of severe opportunistic diseases (ODs) in HIV-infected patients beyond that which is expected from changes in CD4+ T-cell count...
  12. ncbi Scaling up antiretroviral therapy in South Africa: the impact of speed on survival
    Rochelle P Walensky
    The Divisions of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
    J Infect Dis 197:1324-32. 2008
    ..Only 33% of eligible human immunodeficiency virus (HIV)-infected patients in South Africa receive antiretroviral therapy (ART). We sought to estimate the impact of alternative ART scale-up scenarios on patient outcomes from 2007-2012...
  13. ncbi Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Côte d'Ivoire
    Xavier Anglaret
    INSERM U330, , Bordeaux, France
    AIDS 17:575-84. 2003
    ..1/100 PY), serious bacterial morbidity remains the first cause of hospital admission in adults receiving cotrimoxazole in this setting...
  14. ncbi Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire
    Catherine Seyler
    Programme PAC-CI, Abidjan,
    Antivir Ther 8:385-93. 2003
    ..CONCLUSION: Medium-term survival under ART may be as good in Africa as in industrialized countries, provided that patients benefit from access to care for opportunistic infections, including bacterial diseases, tuberculosis and malaria...
  15. ncbi Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from Sub-Saharan Africa
    Xavier Anglaret
    INSERM U 593, Universite Victor Segalen, Bordeaux, France
    J Acquir Immune Defic Syndr 35:320-3. 2004
    ..We suggest that the percentage of deaths known through VSIPs would be a useful indicator to be added when reporting survival data from urban HIV cohort studies in sub-Saharan Africa...
  16. ncbi Nonantiretroviral drug consumption by CD4 cell count in HIV-infected adults: a 5-year cohort study in Côte d'Ivoire
    Nohelly Nombela
    Unité INSERM U 593, Universite Victor Segalen, Bordeaux, Cedex, France
    J Acquir Immune Defic Syndr 41:225-31. 2006
    ..Meanwhile, they roughly suggest that successful antiretroviral treatment, which would stabilize the CD4 count above 500 cells/mm, could reduce by 5-fold the cost of nonantiretroviral drugs in HIV-infected adults in Abidjan...
  17. ncbi Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
    Paula Braitstein
    Lancet 367:817-24. 2006
    ..Timely diagnosis and assessment of treatment eligibility, coupled with free provision of HAART, might reduce this excess mortality...
  18. ncbi Incidence of neutropenia in HIV-infected African adults receiving co-trimoxazole prophylaxis: a 6-year cohort study in Abidjan, Côte d'Ivoire
    Siaka Toure
    , , , 33076 Bordeaux Cedex, France
    Trans R Soc Trop Med Hyg 100:785-90. 2006
    ..The consequences of associating co-trimoxazole with other haematotoxic drugs should be carefully assessed...
  19. ncbi Risk factors for active tuberculosis in adults on highly active antiretroviral therapy in Africa
    Catherine Seyler
    AIDS 20:1463; author reply 1463-5. 2006
  20. ncbi Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings
    Graeme Meintjes
    Institute of Infectious Diseases and Molecular Medicine and Department of Medicine, University of Cape Town, Cape Town, South Africa
    Lancet Infect Dis 8:516-23. 2008
    ..It is envisaged that these definitions could be used by clinicians and researchers in a variety of settings to promote standardisation and comparability of data...
  21. ncbi Urinary pH in HIV-infected adults in Ivory Coast and in France
    Emmanuel Mortier
    AIDS 17:2003-5. 2003
  22. ncbi Are a past history of tuberculosis and WHO clinical stage associated with incident tuberculosis in adults receiving antiretroviral therapy?, reply to Lawn et al
    Eric Ouattara
    AIDS 21:389-90. 2007